Sam Beck's questions to Axsome Therapeutics Inc (AXSM) leadership • Q2 2025
Question
Sam Beck, on for David Holm, asked about the drivers of Sunosi's strong quarter and whether Axsome feels the need to further increase commercial coverage for Auvelity.
Answer
Chief Commercial Officer Ari Maizel attributed Sunosi's strength to strong growth in both the number and productivity of prescribers. Regarding Auvelity, he stated that while 83% total coverage is good, the goal is to cover as much of the market as possible, so they will continue working to add more lives.